Market Capitalization Endring Dato
AbbVie USD 313.64B 40.03B 2024-03
Acadia Pharmaceuticals USD 2.96B 2.18B 2024-03
Agios Pharmaceuticals USD 1.68B 434M 2024-03
Amgen USD 148.35B 5.79B 2024-03
Astellas Pharma JPY 3.04T 709.27B 2023-12
Bayer EUR 44.65B 4.92B 2023-09
Biogen USD 31.4B 6.09B 2024-03
BioMarin Pharmaceutical USD 15.87B 2.29B 2024-03
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 105.66B 1.26B 2024-03
Celldex Therapeutics USD 2.7B 535M 2024-03
Daiichi Sankyo JPY 7.52T 473.2B 2023-12
Eisai JPY 2.09T 376.18B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Esperion Therapeutics USD 340M 235M 2023-12
Exelixis USD 7.26B 205M 2024-03
Genmab DKK 142.73B 22.97B 2023-12
Gilead Sciences USD 90.93B 10.01B 2024-03
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Incyte USD 12.89B 1.18B 2024-03
Insmed USD 3.95B 486M 2024-03
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Sanofi EUR 113.53B 14.8B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Takeda JPY 6.42T 928.65B 2023-12
Teva Pharmaceutical Industries ILS 42.76B 315.46M 2023-12
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03
Xencor USD 1.37B 81M 2024-03



Seattle Genetics Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.